Cognitive decline is among the most feared aspects of ageing. We have generated induced pluripotent stem cells (iPSCs) from 24 people from the Lothian Birth Cohort 1936, whose cognitive ability was tested in childhood and in older age. Peripheral blood mononuclear cells (PBMCs) were reprogrammed using nonintegrating oriP/EBNA1 backbone plasmids expressing six iPSC reprogramming factors (OCT3/4 (POU5F1), SOX2, KLF4, L-Myc, shp53, Lin28, SV40LT). All lines demonstrated STR matched karyotype and pluripotency was validated by multiple methods. These iPSC lines are a valuable resource to study molecular mechanisms underlying individual differences in cognitive ageing and resilience to age-related neurodegenerative diseases.
Resource

Resource utility
The neurobiology of cognitive ability and its decline during ageing are poorly understood. Human iPSC lines from the Lothian Birth Cohort 1936 comprise individuals with rich life-course cognitive performance data (Taylor et al., 2018; Wardlaw et al., 2011) , affording a rare model to investigate molecular mechanisms relevant to differences in brain development, cellular resilience, and vulnerability to pathology.
Resource Details
Human peripheral blood mononuclear cells (PBMCs) were obtained from 24 unrelated members of the Lothian Birth Cohort 1936. Demographic parameters are 50% female (n = 12), 100% white Scottish (Table 1) . All lines showed a normal karyotype ( Fig.1D , sFig. 2-24D) between passages 6-22, with one exception. All five clones of EDi-038-A (a male) karyotyped as monosomy (45,X) (sFig.18D), and thus very likely stems from the source PBMCs. Mosaicism is a relatively common and probably harmless finding in blood cultures from normal females and, though rarer, also in males (Bukvic et al., 2001) . No differences were detected between the original PBMC samples and the corresponding iPSC lines.
All lines were confirmed to be of human origin and iPSCs matched the profile of parent PBMCs by Short Tandem Repeat (STR) analysis. Parent line data was not available for EDi026-A and EDi028-A. Genetic profiles for these lines were compared to the cell line genetic profiles available in the DSMZ STR database and did not match any other reported profiles in the DSMZ database. These profiles were found to be unique and did not match to any previously submitted profiles from the iPSC Core. The genetic profiles established here can be used for future comparisons for these cell lines. Whole genome sequence data for all 24 lines has been deposited at the European Genome-phenome Archive (EGA), which is hosted by the EBI and the CRG, under accession number EGAS00001003819.
An overview of iPSC line characterisation can be found in Table 2 . Figure 1 presents example characterisation data from EDi021-A. Data for all other lines can be found in Supplementary Figures 2-24 .
Materials and Methods
PBMC isolation
Blood samples were collected with NHS Lothian Research Ethics Committee Approval (10/S1103/10). Blood samples were collected in Sodium Citrate BD Vacutainer CPT tubes (BD, Cat. 362761) (three tubes per
and EDi035-A PBMC isolation was performed by Roslin Cells. For all other lines, PBMC isolation was performed by the Edinburgh Clinical Research Facility (ECRF).
Generation of human iPSCs
Generation of human iPSCs lines from PBMCs was performed using nucleofection of episomal plasmids containing POU5F1, SOX2, KLF4, LIN28, L-MYC, TP53shRNA, and SV40LT.
Briefly, ~5×10 6 cells per nucleofection of PBMCs were nucleofected with plasmid mixture 5p on the Amaxa Nucleofector 2D Device with the Amaxa Human T-cell Nucleofector® Kit. Each transfection contained the following seven factors: OCT4, SOX2, KLF4, LMYC, LIN28, SV40LT and p53 shRNA. These were delivered on the following plasmids, together with an EBNA1 plasmid for episomal plasmid maintenance: pEP4 E02S ET2K, pCXLE-hOCT3/4-shp53-F, pCXLEhUL, pCXLE-hSK, and pCXWB-EBNA1. Nucleofected cells were immediately seeded into three wells of a 6-well plate covered with mitomycin treated mouse embryonic feeder (MEF) layer, and fed with 2mL of either αβ T-cell medium (X-vivo10 supplemented with 30U/ml IL-2 and 5ul/well Dynabeads Human T-activator CD3/CD28) or non T-cell medium (αMEM supplemented with 10% FBS, 10ng/ml IL-3, 10ng/ml IL-6, 10ng/ml G-CSF and 10ng/ml GM-CSF). 23181-010) and re-plated at a 1:6 or 1:9 ratio depending on the cell line. The iPSCs were expanded for 6-22
passages during which period various characterization assays were performed. The iPSCs were cryopreserved using CryoStor CS10 (StemCell Technologies) and an isopropanol freezing vessel at -80°C overnight. The cryopreserved vials were subsequently stored in liquid nitrogen tanks for long-term storage. Working Cell Banks (WCB) of iPSCs were cryopreserved at passage 9-14 and then Distribution Cells Banks (DCB) were created between passages 18-22.
Mycoplasma testing
The absence of mycoplasma contamination in the iPSC lines were confirmed monthly using the MycoAlert Detection Kit, a selective biochemical test (LONZA, Cat. LT07-1188).
EBNA-related gene analysis
Genomic DNA (250ng) was harvested from all cell lines and an embryonic stem cell line (H9) was used a negative control. Primers that recognize EBNA1 along with housekeeping gene Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which was used as a housekeeping gene, were included in this study (Table 2) . PCR was run for 35 cycles at 95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds.
TCRB and TCRG T-Cell Clonality Assay
TCRB and TCRG T-Cell Clonality testing was conducted using Gene Rearrangement and Translocation assays from Invivoscribe Technologies, Inc. Genomic DNA was harvested from all iPSC lines using the MagMAX TM DNA Multi-Sample Ultra 2.0 Kit (Cat. A36570) from Applied Biosystems and it was re-suspended to a final concentration of 100-400μg per ml in dilution buffer. Three Clonal Control DNA and one Polyclonal Control DNA provided with the kit were used. PCR was carried out as per the manufacturer's protocol. PCR products were analysed using 6% TBE gel electrophoresis with gel red staining.
Karyotyping
Human PBMC-iPSCs were incubated in Colcemid (100ng/mL; Life Technologies) for 30 minutes at 37°C and then dissociated using TrypLE for 5 minutes. They were then washed in phosphate buffered saline (PBS) and incubated at 37°C in 5mL hypotonic solution (1g KCl, 1g Na Citrate in 400mL water) for 30 minutes. The cells were centrifuged for 2.5 minutes at 1500RPM and re-suspended in fixative (methanol: acetic acid, 3:1) at room temperature for 5 minutes. This was repeated twice, and finally cells were re-suspended in 500μl of fixative solution and submitted to the Cedars-Sinai Clinical Cytogenetics Core for G-band karyotyping.
Karyotyping of each iPSC line was conducted at early and late passage, between passages 6-22.
Immunocytochemistry iPSCs were plated on Matrigel™ Matrix (BD Biosciences)-coated glass coverslips or optical-bottom 96-well plates (Thermo, Cat. 165305) and subsequently fixed in 4% paraformaldehyde (ten minutes, room temperature (RT)). All cells were blocked in 4-5% goat or donkey serum with 0.1% Triton X-100 (one hour, RT) and incubated with primary antibodies (Table 3) for either 3 hours at RT or overnight at 4°C. Cells were then rinsed and incubated in species-specific AF488 or AF594-conjugated secondary antibodies (1:500) (one hour, RT), followed by DAPI (0.5-1μg/ml; Sigma) to counterstain nuclei (10 minutes, RT). Cells were imaged using Nikon/Leica microscopes or Image Express. The iPSCs exhibited an embryonic stem cell like morphology, and expressed a range of pluripotency markers (OCT3/4, NANOG, SOX2, TRA-1-60, TRA-1-81, SSEA4) ( Figure 1B , Supplementary Figures 2-24B ).
Alkaline phosphatase staining
Alkaline phosphatase staining was performed using the Alkaline Phosphatase Staining Kit II (Stemgent, Cat. 00-0055) according to the manufacturer's instructions.
PluriTest
PluriTest was used to assess the pluripotency of undifferentiated iPSCs ( Figure 1C, Supplementary Figures 2-24C ). Cell pellets were sent to Life Technologies Corporation for the PluriTest Service. Total RNA was isolated using the PureLinkTM RNA Mini Kit (Thermo Fisher Scientific) and quantified using NanoDropTM. 100ng total RNA was used to prepare the GeneChip® for the PluriTest™. In this assay, 36,000 transcripts and variants against a >450 sample reference set are assessed for gene expression analysis. A non-iPSC sample was used in this experiment to serve as a control for non-pluripotency. The transcriptome of all samples were analysed and processed in the PluriTest™ algorithm to generate a pluripotency and novelty score. These two scores determine the pluripotency signature of the cell line which is represented in the pluripotency plot. The threshold for pluripotency was >20, and the threshold for novelty was <1.6.
hPSC Scorecard Data Analysis
Applied Biosystems TaqMan®hPSC Scorecard TM Panel (Thermo Fisher Scientific) was used as an additional technique to assess pluripotency and tri-lineage differentiation potential of iPSC lines using real-time qPCR assays (Figure 1E, Supplementary Figures 2-24E ). Total RNA from undifferentiated and EB differentiated iPSC lines was isolated using MagMAX TM mirVana TM Total RNA Isolation Kit (A27828), and 1μg of RNA was used to make cDNA using the High Capacity cDNA Reverse Transcription Kit (4368813), both from Applied Biosystems.
TaqMan qRT-PCR was carried out using the hPSC Scorecard 384w Fast plate and following manufacturer protocol. We analysed the gene expression data from the TaqMan®hPSC Scorecard TM Panel using the webbased hPSC Scorecard TM Analysis Software (Thermo Fisher Scientific).
Embryoid Body (EB) Formation
IPSC lines were allowed to differentiate by EB formation. Briefly, iPSCs were lifted from 3 wells of a 6 well plate using a cell scraper and seeded in a T25 flask treated with poly-HEMA to prevent cell attachment in EB media containing: IMDM basal media (Cat. 12440061), 17% KnockOut Serum Replacement (KOSR; Cat.
10828028), 1% non-essential amino acids (Cat. 11140050), 1% Antibiotic-Antimycotic (Cat. 15240062) and
110µM β-Mercaptoethanol (Cat. 21985023), all from Thermo Fisher. EBs were allowed to form by selfaggregation, grow and differentiate for 14 days in EB culture media replacing it twice a week. Differentiation to endoderm, mesoderm and ectoderm was assessed by TaqMan® hPSC Scorecard™ Assay (Figure 1E , Supplementary Figures 2-24E ).
STR Analysis
Short Tandem Repeat (STR) Analysis is conducted to confirm iPSC genetic identity. For that, a frozen vial of the Quantitative analysis:
Pluritest.
Pluripotency score ≥ 20 and novelty score ≤ 1.6. Figure 1C ; 
